MilliporeSigma:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MilliporeSigma - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7132
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MilliporeSigma, formerly Sigma-Aldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers its solutions to hospitals, biotechnology and pharmaceutical companies, commercial laboratories, universities, industrial companies, governmental institutions, non-profit organizations, diagnostic, and chemical and electronics companies. It operates across the Americas, Asia-Pacific, Europe, the Middle East and Africa. MilliporeSigma is headquartered in St. Louis, Missouri, the US.

MilliporeSigma – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MilliporeSigma, Medical Equipment, Deal Details 10
Asset Purchase 10
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 10
Partnerships 11
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 11
Sigma-Aldrich Enters into Distribution Agreement with LGC 12
Sigma-Aldrich and GenapSys to Co-Market Genius system 13
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 14
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 15
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 16
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 17
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 18
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 19
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 20
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 21
Asset Transactions 22
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 22
Acquisition 24
Merck Acquires Sigma-Aldrich for USD17 Billion 24
Sigma-Aldrich Acquires Cell Marque 26
MilliporeSigma – Key Competitors 27
MilliporeSigma – Key Employees 28
MilliporeSigma – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
May 12, 2017: MilliporeSigma and Stelis Biopharma Open First Joint Bioprocess Scale-up Lab in India 30
Product News 31
May 29, 2018: MilliporeSigma Announces Collaboration with Solvias for New Pyrogen Detection Kit 31
Apr 04, 2018: MilliporeSigma to Launch New Flow Cytometer, Host CellStream Workshop at CYTO 2018 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
MilliporeSigma, Medical Equipment, Key Facts 2
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Deals By Market, 2012 to YTD 2018 8
MilliporeSigma, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience 10
MilliporeSigma Enters into Distribution Agreement with HistoCyte Labs 11
Sigma-Aldrich Enters into Distribution Agreement with LGC 12
Sigma-Aldrich and GenapSys to Co-Market Genius system 13
Sigma-Aldrich Enters Into Distribution Agreement With Biomatrica For Biospecimen Storage Products 14
GE Healthcare Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich 15
Sigma Life Science Enters Into Distribution Agreement With Olink Bioscience For Duolink Technology 16
Sage Labs Enters Into Agreement With Ekam Imaging To Develop Imaging Assays 17
SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor 18
Little Things Factory Enters Into Distribution Agreement With Sigma-Aldrich For Microreactors 19
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 20
Cyprotex Enters Into Licensing Agreement With Sigma For Zinc Finger Nuclease Technology 21
Honeywell International Acquires Research Chemicals Business from Sigma-Aldrich 22
Merck Acquires Sigma-Aldrich for USD17 Billion 24
Sigma-Aldrich Acquires Cell Marque 26
MilliporeSigma, Key Competitors 27
MilliporeSigma, Key Employees 28
MilliporeSigma, Subsidiaries 29
MilliporeSigma, Joint Venture 29

List of Figures
MilliporeSigma, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MilliporeSigma, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MilliporeSigma, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MilliporeSigma, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MilliporeSigma, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MilliporeSigma:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cumberland Pharmaceuticals Inc (CPIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology and cancer supportive care. The company offers branded presc …
  • SDIX, LLC (SDOI):企業の財務及び戦略的SWOT分析
    Summary SDIX, LLC (SDIX), a subsidiary of OriGene Technologies is a biotechnology company that offers immuno-solutions and produce GMP antibodies. The company offers products that include IVD solutions and premade antibiotics. Its IVD solutions offer co-development of analyte-specific reagents, diag …
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務情報
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Chettinad Cement Corporation Ltd:企業の戦略・SWOT・財務分析
    SummaryChettinad Cement Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • The Brink’s Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Brink's Company Mergers and …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Mitsubishi Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • GTS Central Europe:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GTS Central Europe Mergers and …
  • Bukwang PharmCo Ltd (003000):企業財務及び戦略的SWOT分析
    Summary Bukwang PharmCo Ltd (BUKWANG) is a pharmaceutical company that discovers and develops pharmaceutical products. The company provides levovir, thioctacid, legalon, azeptin, and asima, and others. Its pipeline products comprise apatinib mesylate, MLR-1023, and BK-302. BUKWANG also offers servic …
  • DNA2.0, Inc.(製薬・医療分野):企業M&A動向
    Summary DNA2.0, Inc. (DNA2.0) is a biotechnology company. The company develops and offers synthetic biology solutions. Its products include Electra Vector System, expression vectors, proteinpaintbox, cell strains and CRISPR/Cas9. DNA2.0’s Electra Vector System is used for cloning in bacterial, mamma …
  • OAO OPK “Oboronprom”:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OAO OPK "Oboronprom" Mergers an …
  • DURECT Corporation (DRRX):企業のM&A・提携動向(医療機器分野)
    Summary DURECT Corporation (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The co …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable), a subsidiary of Eurocom Group, is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by whi …
  • Power Solution Technologies Public Company Ltd (PSTC):電力:M&Aディール及び事業提携情報
    Summary Power Solution Technologies Public Company Ltd (PST) is an energy company that offers solar products, technology systems, products and services. The company operates through its business divisions such as power and energy, and power producers. Its power and energy division generates datacent …
  • General Datacomm Industries Inc.の企業概要及び財務/SWOT分析
    General Datacomm Industries Inc. Fundamental Company Report is an absolutely essential resource for anyone looking for detailed information on the above-mentioned company. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about General Dataco …
  • Taiflex Scientific Co., Ltd. (8039):企業概要、財務及び戦略的SWOT分析
    Summary Taiflex Scientific Co., Ltd. (Taiflex Scientific) is a flexible copper manufacturer. The company offers products such as photovoltaic module backsheet, insulated metal substrate series, thermal conductive bonding sheet series and FCCL products. Its photovoltaic module backsheet products incl …
  • Camtek Ltd.の企業概要及び財務/SWOT分析
    Camtek Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Camtek Ltd. annual and quarterly forecasts made by stock market experts. The report also enables direct comparison …
  • Izocam Ticaret ve Sanayi A.S.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Izocam Ticaret ve Sanayi A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stri …
  • Mithridion, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mithridion, Inc. Mergers and Ac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆